Harkey Wilmot B. — SEC Form 4 filings
SEC reporting owner CIK 1775952. 9 Form 4 filings on record with FilingPulse; latest filed 2026-03-17.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-01-24 to 2026-03-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 41 shares, $180 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 19.
- Largest priced transaction: sale of 41 shares @ $4.39 ($180) in Evoke Pharma Inc, filed 2025-01-30.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Evoke Pharma Inc (EVOK) | 10% owner | 2 | — | 1 leg · 41 sh · $180 | 6 |
| TALPHERA, INC. (TLPH) | 10% owner | 5 | — | — | 10 |
| AYTU BIOPHARMA, INC (AYTU) | 10% owner | 2 | — | — | 3 |
Form 4 filings — Harkey Wilmot B.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-17 | 4 | TALPHERA, INC. (TLPH) jointly with Nantahala Capital Management, LLC, Mack Daniel | Grant/award (A): 4,266,211 (derivative) @ $0.58 | EDGAR |
| 2025-12-19 | 4 | Evoke Pharma Inc (EVOK) jointly with Nantahala Capital Management, LLC, Mack Daniel | Other (J): 148,153 @ $11 · Other (J): 433,962 (derivative) @ $11.00 · Other (J): 117,019 (derivative) @ $4.71 · Other (J): 117,019 (derivative) @ $4.71 · Other (J): 158,531 (derivative) @ $10.99 · Other (J): 250,627 (derivative) @ $10.99 | EDGAR |
| 2025-06-09 | 4 | AYTU BIOPHARMA, INC (AYTU) jointly with Nantahala Capital Management, LLC, Mack Daniel | Purchase (P): 4,000,000 (derivative) @ $1.50 | EDGAR |
| 2025-04-02 | 4 | TALPHERA, INC. (TLPH) jointly with Nantahala Capital Management, LLC, Mack Daniel | Grant/award (A): 4,266,211 (derivative) @ $0.58 | EDGAR |
| 2025-01-30 | 4 | Evoke Pharma Inc (EVOK) jointly with Nantahala Capital Management, LLC, Mack Daniel | Sale (S): 41 @ $4.39 | EDGAR |
| 2024-06-18 | 4 | AYTU BIOPHARMA, INC (AYTU) jointly with Nantahala Capital Management, LLC, Mack Daniel | Option exercise/expiry (X): 815,217 (derivative) @ $0 · Option exercise/expiry (X): 815,217 (derivative) @ $0 | EDGAR |
| 2024-03-21 | 4 | TALPHERA, INC. (TLPH) jointly with Nantahala Capital Management, LLC, Mack Daniel | Other (J): 324,675 (derivative) | EDGAR |
| 2024-03-15 | 4 | TALPHERA, INC. (TLPH) jointly with Nantahala Capital Management, LLC, Mack Daniel | Option exercise/expiry (X): 755,000 @ $5 · Option exercise/expiry (X): 755,000 (derivative) @ $0 | EDGAR |
| 2024-01-24 | 4 | TALPHERA, INC. (TLPH) jointly with Nantahala Capital Management, LLC, Mack Daniel | Disposition to issuer (D): 2,205,883 (derivative) · Disposition to issuer (D): 2,205,883 (derivative) · Grant/award (A): 2,205,883 (derivative) · Grant/award (A): 2,205,883 (derivative) · Grant/award (A): 6,168,832 (derivative) @ $0.77 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1775952 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →